Melanin Synthesis Inhibitor [EPC]

Melanin Synthesis Inhibitor [EPC] was reported 1138 times

Drugs of the Melanin Synthesis Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 GEMELLA BACTERAEMIA 1 0.5000
1 OCHRONOSIS 16 0.2254
2 PSEUDOFOLLICULITIS BARBAE 3 0.1250
3 AXILLARY WEB SYNDROME 1 0.0476
4 PHARYNGEAL LEUKOPLAKIA 1 0.0370
5 PLEURAL MASS 2 0.0328
6 FOLLICULAR MUCINOSIS 1 0.0303
7 ANAL INJURY 5 0.0289
8 NAEVOID MELANOMA 1 0.0244
9 SKIN SQUAMOUS CELL CARCINOMA METASTATIC 2 0.0211
10 INAPPROPRIATE RELEASE OF PRODUCT FOR DISTRIBUTION 1 0.0208
11 TYPICAL AURA WITHOUT HEADACHE 2 0.0204
12 SECONDARY SYPHILIS 2 0.0202
13 NIGHT CRAMPS 1 0.0196
14 CHLOASMA 9 0.0194
15 POIKILODERMA 2 0.0185
16 POLYGLANDULAR DISORDER 1 0.0147
17 OBSESSIVE RUMINATION 1 0.0143
18 INFECTIVE KERATITIS 1 0.0141
19 AUTOPHONY 1 0.0133
20 POST INFLAMMATORY PIGMENTATION CHANGE 6 0.0132
21 RHEUMATOID ARTHRITIS-ASSOCIATED INTERSTITIAL LUNG DISEASE 1 0.0118
22 DILATED PORES 1 0.0110
23 METASTASES TO THYROID 1 0.0109
24 DEAFNESS PERMANENT 2 0.0102
25 MEDICAL DEVICE SITE INJURY 1 0.0101
26 CHEMICAL INJURY 8 0.0098
27 NEOPLASM SKIN 15 0.0097
28 MANUFACTURING PRODUCTION ISSUE 1 0.0096
29 SKIN HYPOPIGMENTATION 15 0.0085
30 TUMOUR ULCERATION 2 0.0084
31 BLEPHAROPLASTY 1 0.0082
32 SQUAMOUS CELL CARCINOMA OF SKIN 44 0.0073
33 MYOCARDIAL STRAIN 1 0.0072
34 ADMINISTRATION SITE IRRITATION 1 0.0071
35 DERMATOCHALASIS 1 0.0068
36 PREMATURE AGEING 2 0.0068
37 CONTACT LENS INTOLERANCE 1 0.0064
38 SKIN HYPERPIGMENTATION 54 0.0063
39 APPLICATION SITE WOUND 1 0.0061
40 AEROPHAGIA 1 0.0057
41 ABDOMINAL HERNIA REPAIR 1 0.0054
42 MEDICAL DIET 1 0.0051
43 CHRONIC HEPATITIS C 2 0.0051
44 PENILE BLISTER 1 0.0047
45 PRODUCT ADVERTISING ISSUE 1 0.0047
46 LIPASE ABNORMAL 1 0.0045
47 GALLBLADDER CHOLESTEROLOSIS 2 0.0044
48 APPLICATION SITE ACNE 2 0.0041
49 SKIN ATROPHY 23 0.0040
50 PATIENT DISSATISFACTION WITH DEVICE 1 0.0040
51 GINGIVAL EROSION 1 0.0039
52 BONE FRAGMENTATION 2 0.0036
53 INCORRECT PRODUCT STORAGE 43 0.0033
54 ALLERGY TO VACCINE 1 0.0032
55 INCARCERATED HERNIA 1 0.0032
56 TELANGIECTASIA 3 0.0031
57 PLASTIC SURGERY 1 0.0031
58 STASIS DERMATITIS 2 0.0029
59 PIGMENTATION DISORDER 17 0.0028
60 PRODUCT COMPOUNDING QUALITY ISSUE 1 0.0027
61 KERATOCONJUNCTIVITIS SICCA 1 0.0027
62 EXPOSURE TO COMMUNICABLE DISEASE 2 0.0027
63 CAROTID BRUIT 1 0.0026
64 LIPOEDEMA 1 0.0025
65 CEREBRAL ARTERY EMBOLISM 3 0.0025
66 APPLICATION SITE DISCOLOURATION 10 0.0025
67 SUPERFICIAL VEIN THROMBOSIS 2 0.0024
68 LIP PRURITUS 2 0.0023
69 HAEMANGIOMA OF SKIN 1 0.0023
70 PULMONARY VASCULAR DISORDER 1 0.0021
71 DARK CIRCLES UNDER EYES 3 0.0020
72 PYODERMA 1 0.0020
73 APPLICATION SITE EXFOLIATION 8 0.0019
74 SKIN SENSITISATION 2 0.0019
75 FRACTURE PAIN 1 0.0019
76 SKIN DISCOMFORT 5 0.0019
77 GENITAL DISCOMFORT 1 0.0018
78 EYE INFECTION BACTERIAL 1 0.0018
79 TRICHORRHEXIS 5 0.0018
80 ANAL HAEMORRHAGE 5 0.0018
81 LIFE EXPECTANCY SHORTENED 1 0.0018
82 JUGULAR VEIN DISTENSION 1 0.0018
83 NASAL MUCOSAL DISORDER 1 0.0017
84 PROTRUSION TONGUE 1 0.0017
85 EYE BURNS 1 0.0017
86 GINGIVAL HYPERPLASIA 1 0.0017
87 FAT NECROSIS 1 0.0016
88 SKIN FRAGILITY 4 0.0016
89 NEURODEGENERATIVE DISORDER 1 0.0016
90 CHALAZION 1 0.0016
91 SKIN INJURY 5 0.0015
92 ORAL MUCOSAL DISCOLOURATION 1 0.0015
93 CATARACT NUCLEAR 1 0.0015
94 HAND DERMATITIS 1 0.0014
95 OPHTHALMIC MIGRAINE 1 0.0014
96 CUSHING'S SYNDROME 1 0.0014
97 FACIAL DISCOMFORT 1 0.0014
98 PRODUCT DESIGN ISSUE 1 0.0014
99 SKIN BURNING SENSATION 100 0.0014
100 INTENTIONAL UNDERDOSE 10 0.0014
101 LOCAL REACTION 1 0.0013
102 CHOLANGITIS ACUTE 1 0.0013
103 DIAPHRAGMATIC DISORDER 1 0.0013
104 ROSACEA 6 0.0013
105 EYELID EXFOLIATION 1 0.0013
106 TINEA PEDIS 2 0.0013
107 LIP ERYTHEMA 1 0.0013
108 SKIN IRRITATION 57 0.0012
109 POOR QUALITY PRODUCT ADMINISTERED 13 0.0012
110 DEPERSONALISATION 1 0.0012
111 LOWER RESPIRATORY TRACT CONGESTION 2 0.0012
112 ADENOMA BENIGN 1 0.0012
113 FIXED ERUPTION 2 0.0012
114 GENITAL BURNING SENSATION 1 0.0012
115 ENDOCRINE OPHTHALMOPATHY 1 0.0012
116 PAIN OF SKIN 31 0.0012
117 CEREBELLAR ATROPHY 1 0.0011
118 BLOOD ALBUMIN INCREASED 1 0.0011
119 SKIN WEEPING 4 0.0011
120 RASH PAPULAR 25 0.0011
121 APPLICATION SITE DISCOMFORT 2 0.0011
122 TYPE IV HYPERSENSITIVITY REACTION 3 0.0011
123 PRURIGO 1 0.0011
124 PRODUCT PHYSICAL CONSISTENCY ISSUE 6 0.0011
125 IMPATIENCE 2 0.0011
126 SKIN TIGHTNESS 5 0.0011
127 APPLICATION SITE BRUISE 1 0.0010
128 GALLBLADDER INJURY 2 0.0010
129 LYMPHADENECTOMY 1 0.0010
130 DEVICE RELATED THROMBOSIS 1 0.0010
131 KERATITIS 3 0.0010
132 SKIN EXFOLIATION 81 0.0010
133 NASAL INFLAMMATION 1 0.0009
134 SLEEP DEFICIT 2 0.0009
135 BONE DEMINERALISATION 1 0.0009
136 INTRACRANIAL VENOUS SINUS THROMBOSIS 1 0.0009
137 IRON OVERLOAD 1 0.0009
138 PRODUCT SELECTION ERROR 1 0.0009
139 GRAFT VERSUS HOST DISEASE IN SKIN 2 0.0009
140 APPLICATION SITE DRYNESS 3 0.0009
141 DRUG EFFECT VARIABLE 1 0.0009
142 SCAB 10 0.0009
143 LICHENOID KERATOSIS 2 0.0009
144 CHEMICAL BURN 1 0.0009
145 AORTIC THROMBOSIS 1 0.0009
146 BLADDER OPERATION 1 0.0009
147 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 47 0.0009
148 ERYTHEMA 176 0.0009
149 INCISION SITE PAIN 1 0.0009
150 EMBOLISM ARTERIAL 1 0.0008
151 SELF ESTEEM DECREASED 2 0.0008
152 EYELID SKIN DRYNESS 1 0.0008
153 PHARYNGEAL INFLAMMATION 1 0.0008
154 BLOOD IMMUNOGLOBULIN G INCREASED 1 0.0008
155 PENILE SWELLING 1 0.0008
156 APPLICATION SITE SCAR 1 0.0008
157 REBOUND EFFECT 9 0.0008
158 LIP DISCOLOURATION 1 0.0008
159 FRACTURED COCCYX 1 0.0008
160 DERMATITIS CONTACT 9 0.0008
161 PRODUCT COLOUR ISSUE 4 0.0008
162 PROTEIN TOTAL ABNORMAL 1 0.0008
163 COUNTERFEIT PRODUCT ADMINISTERED 1 0.0008
164 DERMATITIS 16 0.0008
165 RADICULOPATHY 2 0.0008
166 ABNORMAL SLEEP-RELATED EVENT 1 0.0008
167 LIP EXFOLIATION 1 0.0008
168 SKIN DISCOLOURATION 34 0.0007
169 SKIN WRINKLING 2 0.0007
170 CLUSTER HEADACHE 1 0.0007
171 APPLICATION SITE INFLAMMATION 1 0.0007
172 HAIR GROWTH ABNORMAL 5 0.0007
173 DISCHARGE 1 0.0007
174 PERIODONTAL DISEASE 1 0.0007
175 MAST CELL ACTIVATION SYNDROME 1 0.0007
176 SKIN HYPERTROPHY 2 0.0007
177 CONNECTIVE TISSUE DISORDER 1 0.0007
178 SKIN SWELLING 6 0.0007
179 SKIN WARM 4 0.0007
180 APPLICATION SITE ERYTHEMA 18 0.0007
181 INTENTIONAL PRODUCT USE ISSUE 58 0.0007
182 REBOUND ACID HYPERSECRETION 2 0.0007
183 MOUTH INJURY 1 0.0007
184 HEAT STROKE 1 0.0007
185 PNEUMONIA PSEUDOMONAL 1 0.0007
186 DIASTOLIC DYSFUNCTION 2 0.0006
187 NEPHROGENIC ANAEMIA 3 0.0006
188 ORAL MUCOSAL ERYTHEMA 1 0.0006
189 ELECTROCARDIOGRAM T WAVE ABNORMAL 1 0.0006
190 INCORRECT DRUG ADMINISTRATION DURATION 18 0.0006
191 APPLICATION SITE PAIN 14 0.0006
192 PHARYNGEAL PARAESTHESIA 1 0.0006
193 INTESTINAL ULCER 1 0.0006
194 ANTIPHOSPHOLIPID SYNDROME 1 0.0006
195 HYPOVENTILATION 2 0.0006
196 PAPILLOMA VIRAL INFECTION 1 0.0006
197 BLOOD CALCIUM ABNORMAL 1 0.0006
198 MITRAL VALVE PROLAPSE 1 0.0006
199 CHOLECYSTITIS CHRONIC 4 0.0006
200 NEOPLASM RECURRENCE 2 0.0006
201 EXPOSURE TO SARS-COV-2 1 0.0006
202 BLADDER NEOPLASM 1 0.0006
203 INTENTIONAL PRODUCT MISUSE 51 0.0006
204 ACUTE SINUSITIS 1 0.0006
205 INCORRECT STORAGE OF DRUG 1 0.0006
206 KIDNEY FIBROSIS 1 0.0006
207 DRUG MONITORING PROCEDURE NOT PERFORMED 1 0.0006
208 CEREBROSPINAL FLUID LEAKAGE 1 0.0005
209 LIP DISORDER 1 0.0005
210 RADIOTHERAPY 1 0.0005
211 PATIENT DISSATISFACTION WITH TREATMENT 1 0.0005
212 ARTERIAL THROMBOSIS 1 0.0005
213 CONVERSION DISORDER 1 0.0005
214 OCULAR HYPERTENSION 1 0.0005
215 EARLY SATIETY 1 0.0005
216 NASAL SEPTUM DEVIATION 1 0.0005
217 DRY SKIN 68 0.0005
218 SKIN PAPILLOMA 2 0.0005
219 EAR HAEMORRHAGE 1 0.0005
220 HYPERAESTHESIA 4 0.0005
221 LARYNGEAL OEDEMA 3 0.0005
222 RENAL MASS 1 0.0005
223 DERMATITIS ALLERGIC 6 0.0005
224 BLEPHAROSPASM 3 0.0005
225 DILATATION VENTRICULAR 1 0.0005
226 DEVICE MATERIAL ISSUE 1 0.0005
227 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 1 0.0005
228 ANAEMIA MACROCYTIC 1 0.0005
229 INTERVERTEBRAL DISC DISORDER 2 0.0005
230 MEDICAL DEVICE PAIN 1 0.0005
231 MUSCLE STRAIN 4 0.0005
232 PERIODONTITIS 1 0.0005
233 OCULAR ICTERUS 2 0.0005
234 GASTRIC BYPASS 1 0.0005
235 CORNEAL DISORDER 1 0.0005
236 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 32 0.0004
237 PNEUMOCYSTIS JIROVECI PNEUMONIA 1 0.0004
238 HAIR TEXTURE ABNORMAL 6 0.0004
239 APPLICATION SITE URTICARIA 1 0.0004
240 PERIARTHRITIS 1 0.0004
241 BREAKTHROUGH PAIN 1 0.0004
242 INTERVERTEBRAL DISC DEGENERATION 4 0.0004
243 LICHEN PLANUS 1 0.0004
244 ORAL SURGERY 1 0.0004
245 PAPULE 3 0.0004
246 SKIN ABRASION 2 0.0004
247 MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE 1 0.0004
248 MEDICATION RESIDUE PRESENT 2 0.0004
249 SCAR 7 0.0004
250 APPLICATION SITE BURN 2 0.0004
251 CARTILAGE INJURY 1 0.0004
252 BLOOD PRESSURE SYSTOLIC ABNORMAL 1 0.0004
253 INJECTION SITE INFLAMMATION 2 0.0004
254 APPLICATION SITE SWELLING 2 0.0004
255 PLATELET DISORDER 1 0.0004
256 ECONOMIC PROBLEM 6 0.0004
257 CHEMICAL BURN OF SKIN 1 0.0004
258 AORTIC ARTERIOSCLEROSIS 1 0.0004
259 MEDICATION RESIDUE 1 0.0004
260 MUSCULOSKELETAL CHEST PAIN 6 0.0004
261 TRISMUS 2 0.0004
262 HERNIA REPAIR 1 0.0004
263 PRODUCT ODOUR ABNORMAL 4 0.0004
264 PERSONALITY DISORDER 1 0.0004
265 TOOTH INFECTION 5 0.0004
266 NASAL DISORDER 1 0.0004
267 ALCOHOL ABUSE 1 0.0004
268 STENT PLACEMENT 3 0.0004
269 RASH MACULAR 13 0.0004
270 GINGIVITIS 2 0.0004
271 SHOCK HAEMORRHAGIC 3 0.0004
272 CLUMSINESS 1 0.0004
273 RHINALGIA 1 0.0004
274 APPLICATION SITE RASH 5 0.0004
275 RED BLOOD CELL COUNT INCREASED 1 0.0004
276 HYPERKERATOSIS 2 0.0004
277 PLEURITIC PAIN 1 0.0004
278 FOOT DEFORMITY 4 0.0004
279 CHOLECYSTITIS INFECTIVE 1 0.0004
280 PERIORBITAL SWELLING 2 0.0004
281 VISUAL DISTURBANCE 2 0.0003
282 LIP PAIN 1 0.0003
283 IMPAIRED QUALITY OF LIFE 5 0.0003
284 HERPES VIRUS INFECTION 2 0.0003
285 FIBULA FRACTURE 1 0.0003
286 MOUTH SWELLING 2 0.0003
287 METASTASES TO LUNG 4 0.0003
288 ANHEDONIA 9 0.0003
289 CONDITION AGGRAVATED 104 0.0003
290 ACNE CYSTIC 1 0.0003
291 NEPHROGENIC SYSTEMIC FIBROSIS 1 0.0003
292 NOCTURIA 4 0.0003
293 CHRONIC KIDNEY DISEASE 25 0.0003
294 END STAGE RENAL DISEASE 6 0.0003
295 HIDRADENITIS 3 0.0003
296 IRITIS 1 0.0003
297 INGUINAL HERNIA 2 0.0003
298 DERMATITIS ACNEIFORM 2 0.0003
299 MEDICAL DEVICE DISCOMFORT 1 0.0003
300 INTRACARDIAC THROMBUS 1 0.0003
301 FIBROSIS 1 0.0003
302 EYELIDS PRURITUS 1 0.0003
303 THERAPY PARTIAL RESPONDER 5 0.0003
304 PRE-EXISTING CONDITION IMPROVED 2 0.0003
305 BLOOD CREATININE DECREASED 1 0.0003
306 NASAL DRYNESS 2 0.0003
307 IRIDOCYCLITIS 1 0.0003
308 RASH ERYTHEMATOUS 15 0.0003
309 LOOSE TOOTH 1 0.0003
310 POOR QUALITY DRUG ADMINISTERED 2 0.0003
311 PRODUCT USE ISSUE 58 0.0003
312 ANTINUCLEAR ANTIBODY POSITIVE 1 0.0003
313 VITAMIN D DEFICIENCY 3 0.0003
314 POSTURE ABNORMAL 1 0.0003
315 SKIN FISSURES 6 0.0003
316 TENDON DISORDER 2 0.0003
317 LIGAMENT SPRAIN 3 0.0003
318 PRODUCT FORMULATION ISSUE 2 0.0003
319 PRODUCT USE IN UNAPPROVED INDICATION 75 0.0003
320 ADVERSE REACTION 4 0.0003
321 OVARIAN CYST 3 0.0003
322 NEPHRITIS 1 0.0003
323 POST-TRAUMATIC STRESS DISORDER 2 0.0003
324 PLANTAR FASCIITIS 1 0.0003
325 EYE SWELLING 11 0.0003
326 CARBOHYDRATE ANTIGEN 125 INCREASED 1 0.0003
327 EAR DISCOMFORT 3 0.0003
328 ECCHYMOSIS 2 0.0003
329 LEFT VENTRICULAR FAILURE 1 0.0003
330 ACNE 22 0.0003
331 LYMPHOEDEMA 2 0.0003
332 EAR PRURITUS 1 0.0003
333 ERYTHEMA NODOSUM 1 0.0003
334 MUSCLE CONTRACTIONS INVOLUNTARY 1 0.0003
335 SCRATCH 3 0.0003
336 GALLBLADDER DISORDER 5 0.0003
337 SWELLING FACE 18 0.0003
338 DEVICE KINK 1 0.0003
339 MAJOR DEPRESSION 2 0.0003
340 UTERINE LEIOMYOMA 2 0.0003
341 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 8 0.0003
342 FOOD INTOLERANCE 1 0.0003
343 SKIN DISORDER 9 0.0003
344 SUNBURN 2 0.0003
345 BLISTER 15 0.0003
346 AUTOIMMUNE THYROIDITIS 1 0.0003
347 PARANASAL SINUS DISCOMFORT 1 0.0003
348 PRODUCT STORAGE ISSUE 1 0.0003
349 OSTEOPENIA 4 0.0003
350 FACE INJURY 1 0.0003
351 PARANASAL SINUS HYPERSECRETION 1 0.0003
352 CONJUNCTIVAL HAEMORRHAGE 1 0.0003
353 GINGIVAL DISORDER 1 0.0003
354 ORAL HERPES 5 0.0003
355 CERVIX CARCINOMA 1 0.0003
356 PRODUCT ADMINISTRATION INTERRUPTED 2 0.0003
357 CHOLECYSTITIS 3 0.0003
358 TRICUSPID VALVE INCOMPETENCE 2 0.0003
359 BLEPHARITIS 1 0.0002
360 OBSESSIVE-COMPULSIVE DISORDER 2 0.0002
361 RHINITIS 2 0.0002
362 POST PROCEDURAL INFECTION 2 0.0002
363 RECURRENT CANCER 1 0.0002
364 CARDIOMEGALY 3 0.0002
365 METASTASES TO BONE 4 0.0002
366 ARTHRITIS BACTERIAL 1 0.0002
367 INJECTION SITE EXTRAVASATION 3 0.0002
368 AORTIC DISSECTION 1 0.0002
369 DRUG EFFECT DECREASED 13 0.0002
370 ACCIDENTAL EXPOSURE 1 0.0002
371 CONGESTIVE CARDIOMYOPATHY 1 0.0002
372 PRODUCT STORAGE ERROR 21 0.0002
373 PULSELESS ELECTRICAL ACTIVITY 1 0.0002
374 ESCHERICHIA URINARY TRACT INFECTION 1 0.0002
375 AORTIC VALVE INCOMPETENCE 1 0.0002
376 PRODUCT CONTAINER ISSUE 2 0.0002
377 ABNORMAL SENSATION IN EYE 1 0.0002
378 CARDIAC MURMUR 2 0.0002
379 HORDEOLUM 1 0.0002
380 LOCAL SWELLING 4 0.0002
381 DIVERTICULUM INTESTINAL 1 0.0002
382 BLOOD CALCIUM INCREASED 2 0.0002
383 ONYCHOMYCOSIS 1 0.0002
384 INTENTIONAL DEVICE MISUSE 1 0.0002
385 PRURITUS 87 0.0002
386 DYSMENORRHOEA 3 0.0002
387 PHYSICAL DISABILITY 1 0.0002
388 FOREIGN BODY IN REPRODUCTIVE TRACT 2 0.0002
389 EMOTIONAL DISTRESS 27 0.0002
390 IRON DEFICIENCY 1 0.0002
391 BLOOD PRESSURE SYSTOLIC DECREASED 1 0.0002
392 HAEMOGLOBIN INCREASED 1 0.0002
393 INJECTION SITE PAPULE 1 0.0002
394 PERIPHERAL COLDNESS 3 0.0002
395 ISCHAEMIA 1 0.0002
396 EYE OPERATION 1 0.0002
397 BLOOD PRESSURE DIASTOLIC INCREASED 1 0.0002
398 LOCALISED OEDEMA 1 0.0002
399 CONJUNCTIVITIS 4 0.0002
400 DEEP VEIN THROMBOSIS 14 0.0002
401 RENAL FUNCTION TEST ABNORMAL 1 0.0002
402 FEELING OF DESPAIR 1 0.0002
403 NEPHROPATHY 2 0.0002
404 CARPAL TUNNEL SYNDROME 3 0.0002
405 DEFORMITY 2 0.0002
406 PREGNANCY WITH IMPLANT CONTRACEPTIVE 1 0.0002
407 SQUAMOUS CELL CARCINOMA 2 0.0002
408 SPINAL DISORDER 2 0.0002
409 FOOT FRACTURE 4 0.0002
410 SPUTUM DISCOLOURED 2 0.0002
411 PULSE ABSENT 1 0.0002
412 ENDOMETRIOSIS 1 0.0002
413 LIMB OPERATION 1 0.0002
414 ATELECTASIS 2 0.0002
415 FIBROMYALGIA 5 0.0002
416 NEURALGIA 5 0.0002
417 RENAL TUBULAR NECROSIS 2 0.0002
418 PANCREATIC DISORDER 1 0.0002
419 EXPIRED DRUG ADMINISTERED 1 0.0002
420 PROTEIN URINE PRESENT 1 0.0002
421 DRY EYE 10 0.0002
422 FLUID INTAKE REDUCED 1 0.0002
423 BONE LOSS 3 0.0002
424 DRUG TOLERANCE 1 0.0002
425 TASTE DISORDER 4 0.0002
426 PATHOLOGICAL FRACTURE 1 0.0002
427 FEMORAL NECK FRACTURE 1 0.0002
428 INITIAL INSOMNIA 2 0.0002
429 INCREASED UPPER AIRWAY SECRETION 1 0.0002
430 HELICOBACTER INFECTION 2 0.0002
431 BONE DENSITY DECREASED 6 0.0002
432 ECZEMA 10 0.0002
433 BLOOD LACTIC ACID INCREASED 1 0.0002
434 POLYARTHRITIS 1 0.0002
435 DRUG ADMINISTERED AT INAPPROPRIATE SITE 2 0.0002
436 INCONTINENCE 2 0.0002
437 ANAL FISTULA 1 0.0002
438 COMPRESSION FRACTURE 1 0.0002
439 ANAL FISSURE 1 0.0002
440 PRODUCT DELIVERY MECHANISM ISSUE 1 0.0002
441 ANAL ABSCESS 1 0.0002
442 DECREASED ACTIVITY 2 0.0002
443 PRURITUS GENERALISED 4 0.0002
444 CHEILITIS 1 0.0002
445 INCORRECT PRODUCT ADMINISTRATION DURATION 4 0.0002
446 SKIN LACERATION 2 0.0002
447 CHOKING SENSATION 1 0.0002
448 PROSTATIC DISORDER 1 0.0002
449 PRODUCT LEAKAGE 1 0.0002
450 CHOLECYSTITIS ACUTE 1 0.0002
451 CARDIAC VALVE DISEASE 1 0.0002
452 NEPHROLITHIASIS 8 0.0002
453 EXERCISE TOLERANCE DECREASED 1 0.0002
454 HYPERTRIGLYCERIDAEMIA 1 0.0002
455 SPINAL PAIN 2 0.0002
456 LYMPHADENOPATHY 6 0.0002
457 GASTROENTERITIS VIRAL 3 0.0002
458 CEREBRAL INFARCTION 4 0.0002
459 CONCOMITANT DISEASE AGGRAVATED 1 0.0002
460 DRUG DIVERSION 1 0.0002
461 APPLICATION SITE IRRITATION 2 0.0002
462 SLEEP APNOEA SYNDROME 3 0.0002
463 FOREIGN BODY SENSATION IN EYES 1 0.0002
464 BURNING SENSATION 11 0.0002
465 THERAPEUTIC RESPONSE UNEXPECTED 7 0.0002
466 INTENTIONAL OVERDOSE 10 0.0002
467 ROTATOR CUFF SYNDROME 2 0.0002
468 APPLICATION SITE VESICLES 1 0.0002
469 ANGINA UNSTABLE 1 0.0002
470 HERPES SIMPLEX 1 0.0002
471 NODULE 2 0.0002
472 POLYP 1 0.0002
473 IMMUNE SYSTEM DISORDER 2 0.0002
474 DERMATITIS ATOPIC 8 0.0002
475 SINUS DISORDER 3 0.0002
476 RASH 66 0.0002
477 EXPIRED PRODUCT ADMINISTERED 5 0.0002
478 JOINT RANGE OF MOTION DECREASED 2 0.0001
479 QUALITY OF LIFE DECREASED 2 0.0001
480 BREAST MASS 1 0.0001
481 POSTOPERATIVE WOUND INFECTION 1 0.0001
482 IMPAIRED GASTRIC EMPTYING 2 0.0001
483 BLOOD TESTOSTERONE DECREASED 1 0.0001
484 INFARCTION 1 0.0001
485 PRODUCT PREPARATION ERROR 3 0.0001
486 ONYCHOCLASIS 1 0.0001
487 RESPIRATION ABNORMAL 1 0.0001
488 DROOLING 1 0.0001
489 RIGHT VENTRICULAR FAILURE 1 0.0001
490 INJURY 10 0.0001
491 EATING DISORDER 3 0.0001
492 PRODUCT SUPPLY ISSUE 1 0.0001
493 POOR QUALITY SLEEP 3 0.0001
494 GRAFT VERSUS HOST DISEASE 1 0.0001
495 DERMATITIS BULLOUS 1 0.0001
496 PRODUCT DISPENSING ERROR 3 0.0001
497 INTERVERTEBRAL DISC PROTRUSION 3 0.0001
498 BLOOD PRESSURE DIASTOLIC DECREASED 1 0.0001
499 ARTHROPOD BITE 1 0.0001
500 SKIN HAEMORRHAGE 2 0.0001
501 HYDRONEPHROSIS 1 0.0001
502 GENERAL SYMPTOM 1 0.0001
503 BLOOD POTASSIUM DECREASED 4 0.0001
504 PAROSMIA 1 0.0001
505 PEMPHIGOID 1 0.0001
506 APPLICATION SITE PRURITUS 3 0.0001
507 COLITIS 5 0.0001
508 DISCOMFORT 8 0.0001
509 BOWEL MOVEMENT IRREGULARITY 1 0.0001
510 WHITE BLOOD CELL COUNT INCREASED 5 0.0001
511 MUSCLE TWITCHING 3 0.0001
512 DIFFUSE LARGE B-CELL LYMPHOMA 1 0.0001
513 HAEMOLYSIS 1 0.0001
514 LIMB DISCOMFORT 4 0.0001
515 ANKLE FRACTURE 2 0.0001
516 TENDONITIS 2 0.0001
517 APHTHOUS ULCER 1 0.0001
518 APNOEA 1 0.0001
519 GASTROINTESTINAL INFLAMMATION 1 0.0001
520 BRAIN FOG 2 0.0001
521 MULTIPLE ALLERGIES 1 0.0001
522 CYANOSIS 2 0.0001
523 PRODUCT USE COMPLAINT 2 0.0001
524 ANXIETY 36 0.0001
525 NASAL DISCOMFORT 1 0.0001
526 DRUG INEFFECTIVE 166 0.0001
527 SCIATICA 2 0.0001
528 HYPERSENSITIVITY 23 0.0001
529 MUSCLE TIGHTNESS 2 0.0001
530 POLYURIA 1 0.0001
531 PHOTOSENSITIVITY REACTION 2 0.0001
532 LIP SWELLING 4 0.0001
533 FUNGAL INFECTION 4 0.0001
534 CELLULITIS 6 0.0001
535 EYE PRURITUS 4 0.0001
536 HEMIPARESIS 2 0.0001
537 FACIAL PARALYSIS 1 0.0001
538 GASTRIC DISORDER 4 0.0001
539 MUSCULOSKELETAL DISCOMFORT 2 0.0001
540 SKIN ULCER 3 0.0001
541 BLOOD MAGNESIUM DECREASED 1 0.0001
542 PSYCHOLOGICAL TRAUMA 1 0.0001
543 EXPOSURE VIA SKIN CONTACT 3 0.0001
544 INCORRECT DOSE ADMINISTERED BY DEVICE 3 0.0001
545 FEELING HOT 7 0.0001
546 AMENORRHOEA 2 0.0001
547 GRIP STRENGTH DECREASED 1 0.0001
548 BLOOD TRIGLYCERIDES INCREASED 2 0.0001
549 RESPIRATORY RATE INCREASED 1 0.0001
550 FACIAL PAIN 1 0.0001
551 THERAPY INTERRUPTED 8 0.0001
552 THIRST 2 0.0001
553 MYOSITIS 1 0.0001
554 THROAT TIGHTNESS 3 0.0001
555 RASH PRURITIC 6 0.0001
556 OSTEOMYELITIS 2 0.0001
557 LIMB INJURY 3 0.0001
558 LUPUS-LIKE SYNDROME 1 0.0001
559 LIP DRY 1 0.0001
560 OPTIC NEURITIS 1 0.0001
561 MOOD ALTERED 3 0.0001
562 EXOSTOSIS 1 0.0001
563 SKIN LESION 3 0.0001
564 INCREASED TENDENCY TO BRUISE 1 0.0001
565 OVARIAN CANCER 1 0.0001
566 UPPER RESPIRATORY TRACT INFECTION 5 0.0001
567 PARAESTHESIA 17 0.0001
568 MENTAL STATUS CHANGES 3 0.0001
569 HEPATIC STEATOSIS 2 0.0001
570 APPENDICITIS 1 0.0001
571 FLANK PAIN 1 0.0001
572 PHOTOPHOBIA 2 0.0001
573 LACERATION 1 0.0001
574 ABORTION INDUCED 1 0.0001
575 OCULAR HYPERAEMIA 5 0.0001
576 PRODUCT PACKAGING ISSUE 1 0.0001
577 PULMONARY EMBOLISM 10 0.0001
578 RECALLED PRODUCT ADMINISTERED 1 0.0001
579 EYE INFLAMMATION 1 0.0001
580 EYE IRRITATION 6 0.0001
581 ACUTE RESPIRATORY FAILURE 2 0.0001
582 AUTOIMMUNE DISORDER 1 0.0001
583 CHOKING 2 0.0001
584 PHARYNGEAL SWELLING 1 0.0001
585 INFLAMMATORY BOWEL DISEASE 1 0.0001
586 COELIAC DISEASE 1 0.0001
587 ALOPECIA 20 0.0001
588 KNEE OPERATION 1 0.0001
589 BODY TEMPERATURE DECREASED 1 0.0001
590 DISABILITY 2 0.0001
591 EMBEDDED DEVICE 1 0.0001
592 HAEMATOCRIT DECREASED 2 0.0001
593 PRESCRIBED UNDERDOSE 2 0.0001
594 BRAIN INJURY 1 0.0001
595 PLEURAL EFFUSION 6 0.0001
596 DRUG LEVEL DECREASED 1 0.0001
597 NEUTROPHIL COUNT INCREASED 1 0.0001
598 EMOTIONAL DISORDER 3 0.0001
599 OSTEOPOROSIS 4 0.0001
600 OROPHARYNGEAL PAIN 9 0.0001
601 SWELLING 9 0.0001
602 PULMONARY HYPERTENSION 2 0.0001
603 ROAD TRAFFIC ACCIDENT 4 0.0001
604 INJECTION SITE DISCOMFORT 1 0.0001
605 FULL BLOOD COUNT ABNORMAL 1 0.0001
606 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 17 0.0001
607 MIGRAINE 9 0.0001
608 BREAST PAIN 1 0.0001
609 BODY HEIGHT DECREASED 1 0.0001
610 IRRITABLE BOWEL SYNDROME 2 0.0001
611 BREAST CANCER METASTATIC 1 0.0001
612 NIGHT SWEATS 3 0.0001
613 HOT FLUSH 7 0.0001
614 OEDEMA 5 0.0001
615 BIPOLAR DISORDER 1 0.0001
616 IMPAIRED HEALING 3 0.0001
617 EYE DISORDER 3 0.0001
618 GASTROINTESTINAL PAIN 1 0.0001
619 MELAENA 2 0.0001
620 HYPERTENSIVE CRISIS 1 0.0001
621 NECK PAIN 5 0.0001
622 SNEEZING 2 0.0001
623 OCULAR DISCOMFORT 1 0.0001
624 FISTULA 1 0.0001
625 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 3 0.0001
626 CHROMATURIA 2 0.0001
627 HEART RATE IRREGULAR 2 0.0001
628 MITRAL VALVE INCOMPETENCE 1 0.0001
629 PRODUCT AVAILABILITY ISSUE 2 0.0001
630 SINUSITIS 9 0.0001
631 INTERNAL HAEMORRHAGE 1 0.0001
632 ILLNESS 9 0.0001
633 CONSTIPATION 19 0.0001
634 HERPES ZOSTER 5 0.0001
635 NIGHTMARE 3 0.0001
636 POST PROCEDURAL HAEMORRHAGE 1 0.0001
637 BLOOD CHOLESTEROL INCREASED 4 0.0001
638 COGNITIVE DISORDER 4 0.0001
639 HYPOXIA 3 0.0001
640 NASAL CONGESTION 5 0.0001
641 SLEEP DISORDER 6 0.0001
642 BLOOD IRON DECREASED 1 0.0001
643 ATAXIA 1 0.0001
644 BACTERAEMIA 1 0.0001
645 PRODUCT PRESCRIBING ERROR 2 0.0001
646 CATARACT 5 0.0001
647 MUSCLE RIGIDITY 1 0.0001
648 URTICARIA 14 0.0001
649 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 4 0.0001
650 CONTUSION 8 0.0001
651 RENAL FAILURE 11 0.0001
652 LOCALISED INFECTION 2 0.0001
653 BURSITIS 1 0.0001
654 VERTIGO 5 0.0001
655 NO THERAPEUTIC RESPONSE 1 0.0001
656 MUSCLE SPASMS 15 0.0001
657 GLOMERULAR FILTRATION RATE DECREASED 1 0.0001
658 ABASIA 2 0.0001
659 GENERALISED OEDEMA 1 0.0001
660 PHARYNGITIS 1 0.0001
661 CYST 1 0.0001
662 ILEUS 1 0.0001
663 HAIR COLOUR CHANGES 1 0.0001
664 AGEUSIA 2 0.0001
665 MEMORY IMPAIRMENT 11 0.0001
666 DYSPNOEA EXERTIONAL 3 0.0001
667 GLYCOSYLATED HAEMOGLOBIN INCREASED 2 0.0001
668 BRAIN OEDEMA 1 0.0001
669 INSOMNIA 21 0.0001
670 FLUID RETENTION 4 0.0001
671 DEVICE DEPLOYMENT ISSUE 1 0.0001
672 HEPATITIS 2 0.0001
673 PAIN 48 0.0001
674 CHEST DISCOMFORT 8 0.0001
675 INFUSION SITE PAIN 1 0.0001
676 METASTASES TO CENTRAL NERVOUS SYSTEM 1 0.0001
677 INFLAMMATION 4 0.0001
678 HIATUS HERNIA 1 0.0001
679 INJECTION SITE INDURATION 1 0.0001
680 RESPIRATORY TRACT INFECTION 2 0.0001
681 PLATELET COUNT INCREASED 1 0.0001
682 ABDOMINAL DISTENSION 8 0.0001
683 BLOOD CREATININE INCREASED 5 0.0001
684 SEDATION 2 0.0001
685 MUSCULOSKELETAL PAIN 4 0.0001
686 ARTHRITIS 6 0.0001
687 JOINT STIFFNESS 2 0.0001
688 INJECTION SITE PRURITUS 5 0.0001
689 GASTROOESOPHAGEAL REFLUX DISEASE 6 0.0001
690 PNEUMONITIS 2 0.0001
691 GINGIVAL BLEEDING 1 0.0001
692 ACUTE HEPATIC FAILURE 1 0.0001
693 CORONARY ARTERY OCCLUSION 1 0.0001
694 HAEMATOCHEZIA 4 0.0001
695 ARTHROPATHY 4 0.0001
696 ORAL DISCOMFORT 1 0.0001
697 BLOOD PRESSURE INCREASED 11 0.0001
698 POLLAKIURIA 3 0.0001
699 MASS 1 0.0001
700 PAIN IN EXTREMITY 21 0.0001
701 BLOOD TEST ABNORMAL 1 0.0001
702 RENAL FAILURE ACUTE 3 0.0001
703 MYALGIA 12 0.0001
704 DIALYSIS 1 0.0001
705 RHEUMATOID ARTHRITIS 8 0.0001
706 INTENTIONAL DOSE OMISSION 2 0.0001
707 RED BLOOD CELL COUNT DECREASED 2 0.0001
708 ARTHRALGIA 29 0.0001
709 PULMONARY ARTERIAL HYPERTENSION 1 0.0001
710 INJECTION SITE HAEMATOMA 1 0.0001
711 BACK PAIN 16 0.0001
712 LIVER FUNCTION TEST ABNORMAL 2 0.0001
713 NEEDLE ISSUE 2 0.0001
714 GASTROENTERITIS 1 0.0001
715 UNDERDOSE 5 0.0001
716 ASCITES 2 0.0001
717 LABORATORY TEST ABNORMAL 2 0.0001
718 LIVER DISORDER 3 0.0001
719 PULMONARY MASS 1 0.0001
720 THROAT IRRITATION 3 0.0001
721 HYPOAESTHESIA ORAL 1 0.0001
722 LACRIMATION INCREASED 2 0.0001
723 STOMATITIS 4 0.0001
724 DRUG DISPENSING ERROR 1 0.0001
725 INSURANCE ISSUE 1 0.0001
726 TINNITUS 3 0.0001
727 HIP ARTHROPLASTY 1 0.0001
728 OVERDOSE 14 0.0001
729 CHEST PAIN 12 0.0001
730 FEMUR FRACTURE 2 0.0001
731 RENAL DISORDER 3 0.0001
732 LUNG INFECTION 1 0.0001
733 BASAL CELL CARCINOMA 1 0.0001
734 SWOLLEN TONGUE 2 0.0001
735 HEAD INJURY 2 0.0001
736 NEUROPATHY PERIPHERAL 6 0.0001
737 RESPIRATORY TRACT CONGESTION 1 0.0001
738 FATIGUE 49 0.0001
739 CYSTITIS 2 0.0001
740 ABSCESS 1 0.0001
741 INJECTION SITE BRUISING 5 0.0001
742 HIP FRACTURE 2 0.0001
743 DRY MOUTH 5 0.0001
744 BACK DISORDER 1 0.0001
745 MANIA 1 0.0001
746 GENERAL PHYSICAL HEALTH DETERIORATION 7 0.0001
747 THERAPEUTIC RESPONSE SHORTENED 2 0.0001
748 BLOOD UREA INCREASED 1 0.0001
749 NASOPHARYNGITIS 11 0.0001
750 TRANSIENT ISCHAEMIC ATTACK 2 0.0001
751 ANGER 2 0.0001
752 PRODUCT QUALITY ISSUE 8 0.0001
753 THERAPY CESSATION 3 0.0001
754 HAEMOGLOBIN DECREASED 6 0.0001
755 PERIPHERAL SWELLING 9 0.0001
756 HAEMATURIA 2 0.0001
757 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1 0.0001
758 ACCIDENTAL EXPOSURE TO PRODUCT 6 0.0001
759 WEIGHT INCREASED 13 0.0001
760 JOINT SWELLING 7 0.0001
761 DEVICE DEFECTIVE 1 0.0001
762 ORTHOSTATIC HYPOTENSION 1 0.0001
763 NERVOUSNESS 3 0.0001
764 DEVICE USE ISSUE 1 0.0001
765 MUSCULOSKELETAL STIFFNESS 5 0.0001
766 EOSINOPHILIA 1 0.0001
767 METASTASES TO LIVER 1 0.0001
768 DEPRESSED MOOD 3 0.0001
769 LYMPHOCYTE COUNT DECREASED 1 0.0001
770 DIABETES MELLITUS INADEQUATE CONTROL 1 0.0001
771 ASPARTATE AMINOTRANSFERASE INCREASED 3 0.0001
772 DRUG ERUPTION 1 0.0001
773 PLATELET COUNT DECREASED 6 0.0001
774 DIZZINESS 28 0.0001
775 ISCHAEMIC STROKE 1 0.0001
776 PRODUCT ADHESION ISSUE 2 0.0001
777 OFF LABEL USE 49 0.0001
778 ABDOMINAL PAIN 13 0.0001
779 GOUT 1 0.0001
780 WRONG TECHNIQUE IN DRUG USAGE PROCESS 2 0.0001
781 HYPERGLYCAEMIA 2 0.0001
782 AGITATION 4 0.0001
783 INFLUENZA 6 0.0001
784 PSORIASIS 7 0.0001
785 MIDDLE INSOMNIA 1 0.0001
786 EPISTAXIS 4 0.0001
787 HEPATIC CIRRHOSIS 1 0.0001
788 BLOOD SODIUM DECREASED 1 0.0001
789 FRACTURE 1 0.0001
790 BLOOD URINE PRESENT 1 0.0001
791 GASTRIC ULCER 1 0.0001
792 PROTEINURIA 1 0.0001
793 DIABETES MELLITUS 4 0.0001
794 INCREASED APPETITE 1 0.0001
795 ACUTE KIDNEY INJURY 8 0.0001
796 PULMONARY FIBROSIS 1 0.0001
797 POST PROCEDURAL COMPLICATION 1 0.0001
798 LOWER LIMB FRACTURE 1 0.0001
799 HERNIA 1 0.0001
800 PRESCRIBED OVERDOSE 1 0.0001
801 DYSTONIA 1 0.0001
802 EAR PAIN 1 0.0001
803 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
804 SURGERY 3 0.0001
805 MENORRHAGIA 1 0.0001
806 DYSPEPSIA 5 0.0001
807 DISEASE PROGRESSION 6 0.0001
808 DISORIENTATION 2 0.0001
809 BLOOD PRESSURE ABNORMAL 1 0.0001
810 COMPLICATION OF DEVICE INSERTION 1 0.0001
811 PREGNANCY 1 0.0000
812 IRRITABILITY 3 0.0000
813 PRODUCT PHYSICAL ISSUE 1 0.0000
814 PRODUCT ADMINISTRATION ERROR 1 0.0000
815 THERAPEUTIC RESPONSE DECREASED 3 0.0000
816 SUICIDE ATTEMPT 3 0.0000
817 EXTRA DOSE ADMINISTERED 2 0.0000
818 FEEDING DISORDER 1 0.0000
819 NEUTROPHIL COUNT DECREASED 2 0.0000
820 ALANINE AMINOTRANSFERASE INCREASED 3 0.0000
821 RIB FRACTURE 1 0.0000
822 INFLUENZA LIKE ILLNESS 4 0.0000
823 DEPRESSION 11 0.0000
824 TREATMENT FAILURE 4 0.0000
825 EXPOSURE DURING PREGNANCY 3 0.0000
826 FALL 16 0.0000
827 ABDOMINAL DISCOMFORT 8 0.0000
828 MOUTH ULCERATION 1 0.0000
829 HALLUCINATION, VISUAL 1 0.0000
830 HYPERTENSION 10 0.0000
831 ANAEMIA 9 0.0000
832 JOINT INJURY 1 0.0000
833 DIARRHOEA 30 0.0000
834 RHINORRHOEA 3 0.0000
835 ALTERED STATE OF CONSCIOUSNESS 1 0.0000
836 WHITE BLOOD CELL COUNT DECREASED 5 0.0000
837 VAGINAL HAEMORRHAGE 2 0.0000
838 DEVICE DISLOCATION 2 0.0000
839 PRODUCT DOSE OMISSION 3 0.0000
840 GLOSSODYNIA 1 0.0000
841 HEADACHE 28 0.0000
842 GASTROINTESTINAL DISORDER 4 0.0000
843 THERAPY NON-RESPONDER 2 0.0000
844 PANCREATITIS ACUTE 1 0.0000
845 ASTHMA 5 0.0000
846 LOWER RESPIRATORY TRACT INFECTION 2 0.0000
847 ABDOMINAL PAIN UPPER 9 0.0000
848 SUICIDAL IDEATION 4 0.0000
849 INJECTION SITE REACTION 3 0.0000
850 ADVERSE EVENT 4 0.0000
851 PYREXIA 15 0.0000
852 WEIGHT DECREASED 12 0.0000
853 COUGH 12 0.0000
854 PALPITATIONS 5 0.0000
855 ASTHENIA 16 0.0000
856 PRODUCTIVE COUGH 2 0.0000
857 GAIT DISTURBANCE 8 0.0000
858 MOBILITY DECREASED 3 0.0000
859 BLOOD PRESSURE FLUCTUATION 1 0.0000
860 DIABETIC KETOACIDOSIS 1 0.0000
861 LUNG DISORDER 2 0.0000
862 PRODUCT DOSE OMISSION ISSUE 12 0.0000
863 LIVER INJURY 1 0.0000
864 BRONCHITIS 3 0.0000
865 OSTEONECROSIS OF JAW 1 0.0000
866 DYSGEUSIA 3 0.0000
867 VISUAL IMPAIRMENT 5 0.0000
868 INJECTION SITE ERYTHEMA 5 0.0000
869 SYNCOPE 4 0.0000
870 COVID-19 7 0.0000
871 ABDOMINAL PAIN LOWER 1 0.0000
872 FLUSHING 4 0.0000
873 NAUSEA 31 0.0000
874 INJECTION SITE SWELLING 3 0.0000
875 INJECTION SITE PAIN 12 0.0000
876 ERECTILE DYSFUNCTION 1 0.0000
877 DYSPNOEA 22 0.0000
878 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 1 0.0000
879 HYPERHIDROSIS 5 0.0000
880 ANAPHYLACTIC SHOCK 1 0.0000
881 HAEMORRHAGE 4 0.0000
882 SPEECH DISORDER 2 0.0000
883 GASTRITIS 1 0.0000
884 EAR INFECTION 1 0.0000
885 THROMBOSIS 3 0.0000
886 JAUNDICE 1 0.0000
887 FREQUENT BOWEL MOVEMENTS 1 0.0000
888 TREATMENT NONCOMPLIANCE 2 0.0000
889 RESPIRATORY DISTRESS 1 0.0000
890 ABNORMAL DREAMS 1 0.0000
891 ANAPHYLACTIC REACTION 2 0.0000
892 VOMITING 17 0.0000
893 DIVERTICULITIS 1 0.0000
894 SEPSIS 4 0.0000
895 HAEMOPTYSIS 1 0.0000
896 RENAL IMPAIRMENT 3 0.0000
897 OXYGEN SATURATION DECREASED 2 0.0000
898 EYE PAIN 2 0.0000
899 URINARY TRACT INFECTION 6 0.0000
900 ANGINA PECTORIS 1 0.0000
901 HYPERSOMNIA 1 0.0000
902 SOMNOLENCE 7 0.0000
903 BALANCE DISORDER 3 0.0000
904 INFECTION 5 0.0000
905 ACUTE MYOCARDIAL INFARCTION 1 0.0000
906 PSYCHOTIC DISORDER 1 0.0000
907 DEVICE ISSUE 3 0.0000
908 RESPIRATORY DISORDER 1 0.0000
909 CORONARY ARTERY DISEASE 1 0.0000
910 ILL-DEFINED DISORDER 2 0.0000
911 OEDEMA PERIPHERAL 4 0.0000
912 INJECTION SITE RASH 1 0.0000
913 HOSPITALISATION 5 0.0000
914 CARDIAC DISORDER 3 0.0000
915 DYSPHAGIA 3 0.0000
916 MOOD SWINGS 1 0.0000
917 HYPOTHYROIDISM 1 0.0000
918 AMNESIA 2 0.0000
919 OSTEONECROSIS 1 0.0000
920 HEART RATE INCREASED 3 0.0000
921 DECREASED APPETITE 7 0.0000
922 TREMOR 5 0.0000
923 GAIT INABILITY 1 0.0000
924 DRUG EXPOSURE DURING PREGNANCY 1 0.0000
925 HEPATIC ENZYME INCREASED 2 0.0000
926 VISION BLURRED 4 0.0000
927 HEART RATE DECREASED 1 0.0000
928 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2 0.0000
929 INCORRECT ROUTE OF DRUG ADMINISTRATION 1 0.0000
930 CEREBRAL HAEMORRHAGE 1 0.0000
931 DRUG EFFECT INCOMPLETE 1 0.0000
932 CRYING 1 0.0000
933 PANIC ATTACK 1 0.0000
934 RESTLESSNESS 1 0.0000
935 DYSURIA 1 0.0000
936 INJECTION SITE MASS 1 0.0000
937 HYPOAESTHESIA 4 0.0000
938 PLASMA CELL MYELOMA 1 0.0000
939 INJECTION SITE HAEMORRHAGE 2 0.0000
940 FEELING ABNORMAL 6 0.0000
941 CARDIAC FAILURE CONGESTIVE 2 0.0000
942 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 5 0.0000
943 DEVICE BREAKAGE 1 0.0000
944 BLINDNESS 1 0.0000
945 LUNG NEOPLASM MALIGNANT 1 0.0000
946 CARDIAC ARREST 2 0.0000
947 DRUG DOSE OMISSION 4 0.0000
948 CARDIO-RESPIRATORY ARREST 1 0.0000
949 CEREBROVASCULAR ACCIDENT 4 0.0000
950 OSTEOARTHRITIS 1 0.0000
951 RECTAL HAEMORRHAGE 1 0.0000
952 DEVICE LEAKAGE 1 0.0000
953 MYOCARDIAL INFARCTION 4 0.0000
954 ANGIOEDEMA 1 0.0000
955 PULMONARY OEDEMA 1 0.0000
956 ADVERSE DRUG REACTION 2 0.0000
957 HYPOKALAEMIA 1 0.0000
958 BLOOD GLUCOSE INCREASED 4 0.0000
959 ARRHYTHMIA 1 0.0000
960 COMA 1 0.0000
961 BLOOD GLUCOSE DECREASED 1 0.0000
962 AGGRESSION 1 0.0000
963 PANCREATITIS 1 0.0000
964 BRADYCARDIA 1 0.0000
965 PNEUMONIA 6 0.0000
966 MALAISE 8 0.0000
967 MEDICATION ERROR 1 0.0000
968 THROMBOCYTOPENIA 2 0.0000
969 FLATULENCE 1 0.0000
970 MUSCULAR WEAKNESS 2 0.0000
971 CONVULSION 1 0.0000
972 DYSPHONIA 1 0.0000
973 CHILLS 2 0.0000
974 LOSS OF CONSCIOUSNESS 2 0.0000
975 DEVICE EXPULSION 1 0.0000
976 DEVICE DIFFICULT TO USE 1 0.0000
977 INFUSION RELATED REACTION 1 0.0000
978 DEHYDRATION 2 0.0000
979 NEOPLASM MALIGNANT 1 0.0000
980 HYPOTENSION 3 0.0000
981 MULTIPLE SCLEROSIS RELAPSE 1 0.0000
982 RESPIRATORY FAILURE 1 0.0000
983 INCORRECT DOSE ADMINISTERED 3 0.0000
984 DRUG INTERACTION 2 0.0000
985 GASTROINTESTINAL HAEMORRHAGE 1 0.0000
986 BREAST CANCER 1 0.0000
987 ATRIAL FIBRILLATION 1 0.0000
988 NEUTROPENIA 1 0.0000
989 CONFUSIONAL STATE 1 0.0000
990 NO ADVERSE EVENT 1 0.0000
991 DEATH 1 0.0000